1. Home
2. Federal Resources
3. Programs/Conferences
4. Treatment and Care

Treatment and Care

Federal Funding for the Care and Treatment of HIV/AIDS

As treatment for HIV/AIDS becomes more complex and multidisciplinary, so too does the need for funding and support. Federal programs provide financial resources that make care available to people living with HIV/AIDS.

Health Resources and Services Administration

Ryan White HIV AIDS Program
The Ryan White HIV/AIDS Program provides HIV-related health services for those who do not have sufficient healthcare coverage or financial resources to cover their HIV care needs. The program works with cities, states, and local community-based organizations to supply services to more than half a million people each year.

The majority of Ryan White funds sustain primary medical care and essential support services. A smaller (but equally critical) portion is used to fund technical assistance, clinical training, and research on innovative models of care. The Ryan White Program is separated into five funding areas:

• Part A: Eligible Metropolitan Areas and Transitional Grant Areas
  Provides emergency assistance to Eligible Metropolitan Areas (EMAs) and Transitional Grant Areas (TGAs) that are most severely affected by the HIV/AIDS epidemic.
• Part B: States and Territories
  Provides grants to all 50 states, the District of Columbia, Puerto Rico, Guam, the U.S. Virgin Islands, and 5 U.S. Pacific Territories or associated jurisdictions.
• Part C: Early Intervention Services
  Funds comprehensive primary healthcare in an outpatient setting for people living with HIV disease.
• Part D: Services for Women, Infants, Youth, Children, and their Families
  Grantees provide family-centered care involving outpatient or ambulatory care (directly or through contracts) for women, infants, children, and youth with HIV/AIDS. Grantees are expected to provide primary medical care, treatment, and support services to improve access to healthcare.
• Part F:
  Special Projects of National Significance (SPNS): Funds innovative models of care and supports the development of effective delivery systems for HIV care to underserved populations diagnosed with HIV infection.
  
  AIDS Education and Training Centers (AETC): Supports a network of 11 regional centers (and more than 130 local sites) that conduct targeted, multidisciplinary education and training programs for healthcare providers treating people living with HIV/AIDS. The AETCs serve all 50 states, the District of Columbia, the Virgin Islands, Puerto Rico, and the 6 U.S. Pacific jurisdictions.
  
  Dental Programs: Funds from all Ryan White grant programs can support oral health services—but two programs focus specifically on funding oral healthcare for people with HIV: the Dental Reimbursement Program (DRP) and the Community-Based Dental Partnership Program (CBDPP).
  
  Minority AIDS Initiative (MAI): Provides funding to evaluate and address the disproportionate impact of HIV/AIDS on women and minorities.

For more information, see HRSA’s Ryan White HIV/AIDS Program and History of the Ryan White HIV/AIDS Program.

Federal HIV/AIDS Treatment Guidelines

In addition to providing funding for the treatment and care of people living with HIV/AIDS, the U.S. Department of Health and Human Services (HHS) also publishes multiple guidelines to assist providers in offering this care. These guidelines are developed in collaboration with agencies across the Federal government, and in conjunction with clinicians and care providers across the country:

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, 2008
Developed by the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents—a working group of the Office of AIDS Research’s Advisory Council (OARAC).

Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States, 2008
Guidelines for treating pregnant women who are living with HIV and for preventing HIV transmission to their unborn babies.

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
Guidelines for clinicians who treat HIV infection in young children, typically aged 0-12 years old. These guidelines contain specific and supplemental information on antiretroviral use in children and infants, including adverse drug reactions.

• Supplement I: Pediatric Antiretroviral Drug Information
• Supplement II: Managing Complications of HIV Infection in HIV-Infected Children on Antiretroviral Therapy
• Supplement III: Adverse Drug Effects

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents, 2008
General treatment guidelines for preventing and treating opportunistic infections in adults with HIV, including specific information on prophylaxis and treatment options for advanced illness.

Guidelines for Prevention and Treatment of Opportunistic Infections among HIV-Exposed and HIV-Infected Children, 2008
Guidelines similar to those for adults, but with specific information on opportunistic infections more commonly seen in pediatric patients, as well as pediatric guidelines for pharmacological treatments.

For a comprehensive list of these guidelines, as well as options for a PDA version, see AIDSinfo’s Clinical Guidelines Portal.